p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors

被引:62
作者
Li, Baozong [1 ]
Cheng, Qian [1 ]
Li, Zhenyu [1 ]
Chen, Jiandong [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA
基金
美国国家卫生研究院;
关键词
p53; p21; PUMA; MDM2; MDMX; germ cell tumor; HUMAN EMBRYONAL CARCINOMA; FAS-MEDIATED APOPTOSIS; CISPLATIN RESISTANCE; ACTIVATION; CANCER; PROTEIN; GENE; PATHWAY; MUTATIONS; AMPLIFICATION;
D O I
10.4161/cc.9.7.11255
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Testicular germ cell tumors (TGCT) are unique in their excellent response to DNA-damaging chemotherapy. Mutation of p53 is rare in both untreated and relapsed TGCTs, suggesting that p53 fails to respond effectively against malignant transformation in germ cells. previous studies implicated the presence of a poorly defined TGCT-specific mechanism of p53 inactivation. Here we show that disruption of p53-mdm2 binding using the MDM2-specific inhibitor Nutlin activates p53 in TGCT cells and is sufficient to induce strong apoptosis. Knockdown of MDMX cooperates with Nutlin to activate p53. Surprisingly, we found that p53 activation induced a two-fold increase in MDMX mRNA and protein expression in TGCT cells. A p53-responsive promoter is identified in MDMX intron 1 that contains a functional p53-binding site, suggesting that MDMX also functions as a negative feedback regulator of p53 in a cell line-dependent fashion. these findings suggest that MDM2 and MDMX are responsible for the functional inactivation of p53 in TGCT. Furthermore, TGCT cells are unique in having a strong apoptosis response to p53. Direct activation of p53 by targeting MDM2 and MDMX may provide a backup approach for the treatment of TGCTs resistant to DNA-damaging drugs.
引用
收藏
页码:1411 / 1420
页数:10
相关论文
共 47 条
[1]   Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis [J].
Alt, JR ;
Greiner, TC ;
Cleveland, JL ;
Eischen, CM .
EMBO JOURNAL, 2003, 22 (06) :1442-1450
[2]   MDM2 SNP309 accelerates colorectal tumour formation in women [J].
Bond, Gareth L. ;
Menin, Chiara ;
Bertorelle, Roberta ;
Alhopuro, Pia ;
Aaltonen, Lauri A. ;
Levine, Arnold J. .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (12) :950-952
[3]  
Chresta CM, 1996, CANCER RES, V56, P1834
[4]   p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53 [J].
Curtin, JC ;
Spinella, MJ .
ONCOGENE, 2005, 24 (09) :1481-1490
[5]   Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function [J].
Curtin, JC ;
Dragnev, KH ;
Sekula, D ;
Christie, AJ ;
Dmitrovsky, E ;
Spinella, MJ .
ONCOGENE, 2001, 20 (20) :2559-2569
[6]   Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity [J].
Danovi, D ;
Meulmeester, E ;
Pasini, D ;
Migliorini, D ;
Capra, M ;
Frenk, R ;
de Graaf, P ;
Francoz, S ;
Gasparini, P ;
Gobbi, A ;
Helin, K ;
Pelicci, PG ;
Jochemsen, AG ;
Marine, JC .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) :5835-5843
[7]   Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours [J].
di Pietro, A ;
de Vries, EGE ;
Gietema, JA ;
Spierings, DCJ ;
de Jong, S .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (12) :2437-2456
[8]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[9]   Regulation of MDMX expression by mitogenic signaling [J].
Gilkes, Daniele M. ;
Pan, Yu ;
Coppola, Domenico ;
Yeatman, Timothy ;
Reuther, Gary W. ;
Chen, Jiandong .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (06) :1999-2010
[10]   MDMX regulation of p53 response to ribosomal stress [J].
Gilkes, Daniele M. ;
Chen, Lihong ;
Chen, Jiandong .
EMBO JOURNAL, 2006, 25 (23) :5614-5625